Table 1

Patient characteristics

Number of patients21
Median age (years)55 (37–80)a
Median Karnofsky performance status90%
Estrogen receptor status
 Positive17
 Negative3
 Unknown1
Prior therapy
 Median number of regimens
  Chemotherapy3 (0–7)a
  Hormonal therapy3 (0–4)a
Metastatic disease
 Median number of sites2
 No. of patients with metastatic sites
  Bone10 (48%)
  Liver8 (38%)
  Lung10 (48%)
  Soft tissue7 (33%)
  • a Range.